ONYX PHARMACEUTICALS INC Operating Cash Flow
ONYX PHARMACEUTICALS INC reported Operating Cash Flow of -$86.98 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-08-06
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2012-06-30 was -$42.61M.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was -$44.36M.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was $129.95M.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-09-30 was -$17.50M, a 129.61% decline year-over-year.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2011 was $50.55M, a 78.25% increase from fiscal 2010.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2010 was $28.36M, a 19.15% decline from fiscal 2009.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2009 was $35.07M.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2008 was -$8.45M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2012-06-30 | -$42.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | -$86.98M 10-Q · filed 2012-08-06 | $42.97M derived: sum of 3 quarters · filed 2012-08-06 | $25.48M derived: sum of 4 quarters · filed 2012-08-06 |
| 2012-03-31 | -$44.36M 10-Q · filed 2012-05-04 | $85.59M derived: sum of 2 quarters · filed 2012-05-04 | $68.09M derived: sum of 3 quarters · filed 2012-05-04 | $50.30M derived: sum of 4 quarters · filed 2012-08-06 |
| 2011-12-31 | $129.95M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $112.45M derived: sum of 2 quarters · filed 2012-02-27 | $94.67M derived: sum of 3 quarters · filed 2012-08-06 | $50.55M 10-K · filed 2012-02-27 |
| 2011-09-30 | -$17.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$35.28M derived: sum of 2 quarters · filed 2012-08-06 | -$79.41M 10-Q · filed 2011-11-03 | -$86.53M derived: sum of 4 quarters · filed 2012-08-06 |
| 2011-06-30 | -$17.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | -$61.91M 10-Q · filed 2012-08-06 | -$69.03M derived: sum of 3 quarters · filed 2012-08-06 | -$9.93M derived: sum of 4 quarters · filed 2012-08-06 |
| 2011-03-31 | -$44.12M 10-Q · filed 2012-05-04 | -$51.25M derived: sum of 2 quarters · filed 2012-05-04 | $7.86M derived: sum of 3 quarters · filed 2012-05-04 | -$10.32M derived: sum of 4 quarters · filed 2012-05-04 |
| 2010-12-31 | -$7.13M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $51.98M derived: sum of 2 quarters · filed 2012-02-27 | $33.80M derived: sum of 3 quarters · filed 2012-02-27 | $28.36M 10-K · filed 2012-02-27 |
| 2010-09-30 | $59.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $40.92M derived: sum of 2 quarters · filed 2011-11-03 | $35.48M 10-Q · filed 2011-11-03 | $39.70M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | -$18.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | -$23.62M 10-Q · filed 2011-08-09 | -$19.40M derived: sum of 3 quarters · filed 2012-02-27 | -$5.04M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | -$5.44M 10-Q · filed 2011-05-10 | -$1.22M derived: sum of 2 quarters · filed 2012-02-27 | $13.14M derived: sum of 3 quarters · filed 2012-02-27 | |
| 2009-12-31 | $4.22M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $18.58M derived: sum of 2 quarters · filed 2012-02-27 | $35.07M 10-K · filed 2012-02-27 | |
| 2009-09-30 | $14.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-03 | $30.85M 10-Q · filed 2010-11-03 | ||
| 2009-06-30 | $16.49M 10-Q · filed 2010-08-04 | |||
| 2008-12-31 | -$8.45M 10-K · filed 2011-02-23 |